期刊文献+

儿童静脉注射丙种球蛋白治疗不敏感川崎病16例的临床特点及效果分析 被引量:5

Analysis of the clinical characteristics and effect of Kawasaki disease with insensitivity for intravenous injection gamma globulin in 16 cases of children
下载PDF
导出
摘要 目的:探讨丙种球蛋白不敏感川崎病的临床特点及治疗效果。方法:收治216例川崎病患儿,其中对丙种球蛋白不敏感16例,分析其临床特点及治疗效果。结果:敏感组和不敏感组在血沉、乳酸脱氢酶、C反应蛋白、血红蛋白、白细胞总数方面比较,差异无统计学意义(P>0.05),而在白蛋白指标方面比较,差异有统计学意义(P<0.05),经过治疗,白细胞总数、C反应蛋白和血沉明显降低(P<0.05),血红蛋白和血细胞比容变化,差异无统计学意义(P>0.05)。结论:男性患儿发病率较高,冠状动脉病变发生率高是丙种球蛋白不敏感川崎病的临床特点,阿司匹林联合丙种球蛋白治疗疗效确切。 ObjectiveTo explore the clinical characteristics and effect of Kawasaki disease with insensitivity for intravenousinjection gamma globulin.Methods:216 cases of children with Kawasaki disease were selected.Among them,16 cases was notsensitive for gamma globulin.We analyzed the clinical characteristics and treatment effect.Results:In the sensitive group and thenon sensitive group,there were no statistically significant differences in the erythrocyte sedimentation rate,lactate dehydrogenase,C reaction protein,hemoglobin and total number of white blood cells(P〉0.05),but there was significant difference in albuminindex(P〈0.05).After treatment,the total number of white blood cells,C reactive protein and erythrocyte sedimentation rate weresignificantly decreased(P〈0.05),and there were no significant differences in hemoglobin and hematocrit changes(P〉0.05).Conclusion:The incidence of males was higher,the high incidence of coronary artery disease was a clinical feature of Kawasakidisease with insensitivity for intravenous injection gamma globulin.The curative effect of aspirin combined with gamma globulinwas exact.
作者 李红霞
出处 《中国社区医师》 2016年第33期48-48,50,共2页 Chinese Community Doctors
关键词 不敏感川崎病 丙种球蛋白 临床特点 Kawasaki disease with insensitivity Gamma globulin Clinical characteristics
  • 相关文献

参考文献2

二级参考文献17

  • 1张清友,杜军保.不完全川崎病的诊治现状[J].中华儿科杂志,2006,44(5):339-341. 被引量:149
  • 2杜军保.川崎病的诊断与鉴别诊断[J].中国实用儿科杂志,2006,21(10):727-728. 被引量:45
  • 3彭文平,朱红枫.川崎病发病机理的研究进展[J].泸州医学院学报,2007,30(1):80-82. 被引量:2
  • 4胡亚美 江载芳.诸福棠实用儿科学[M] 7版[M].北京:人民卫生出版社,2002.698-705.
  • 5Du ZD,Zhang TH,Li T,et al.Epidemiologic pictures of Kawasaki disease in Beijing from 1995 through 1999[J].Pediat Infect Dis J,2002,21 (2):103-107.
  • 6Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association[J].Pediatrics,2004,114 ;1708-1733.[2]Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association[J].Pediatrics,2004,114 ;1708-1733.
  • 7Freeman AF,Shulman ST.Refractory Kawasaki disease[J].Pediatr Infect Dis J,2004,23(5):463-464.
  • 8Yanagawa H,Sonobe T.Changes in the diagnostic guidelines for Kawasaki disease.In:Yanagawa H,Nakamuru Y,Yashiro M,Kawasaki T,editors.Epidemiology of Kawasaki disease:a 30-year achievement[M].Tokyo:Shindan-To-Chiryosha,2004:24 -32.
  • 9Han RK,Silverman ED,Newman A,et al.Management and outcome of recurrent fever after intial intrarenous gammaglobulin therapy in acute Kawasaki disease[J].Arch Pediatr Adolesc Med,2000,154 (7):694-699.
  • 10Wright DA,Newburger JW,Baker A,et al.Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids[J].J Pediatr,1996,128:146-149.

共引文献89

同被引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部